The genetic background of CHH reversal is still unclear, however, the recently identified IGSF10 and GNRHR variants in addition to previously reported TAC3 and TACR3 variants need further studies for clarification of their pathogenic role (Amato et al. 2019). The gene discussed is TAC3; the disease is cartilage-hair hypoplasia.